NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

Analysts downgraded XENE, NFLX and MGA, while raising price targets for OCS, INSW, ABEO and STNG.

Abeona Therapeutics had a busy week with treatment network expansion, an FDA approval tied to a lice

Cantor Fitzgerald analyst Kristen Kluska maintains Abeona Therapeutics (NASDAQ:ABEO) with a Overw

FAYUVI is a highly anticipated, first-ever treatment option with the potential to stop or slow the d

Roth Capital analyst Boobalan Pachaiyappan initiates coverage on Abeona Therapeutics (NASDAQ:ABEO

Oppenheimer analyst Jeff Jones maintains Abeona Therapeutics (NASDAQ:ABEO) with a Outperform and

Abeona Therapeutics (NASDAQ:ABEO) held its second-quarter earnings conference call on Thursday. Belo

Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.9% to $0.17 during Thursday's

Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(0.35) per share which missed the an

The Centers for Medicare & Medicaid Services (CMS) has granted New Technology Add-On Payment (NT

Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cel

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) w

Abeona Therapeutics Inc. (NASDAQ: ABEO) reported first-quarter earnings Wednesday before the market

Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(0.30) per share which beat the anal

Abeona Therapeutics Inc. (NASDAQ:ABEO), a commercial-stage biopharmaceutical company developing gene

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) w

Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(0.34) per share which beat the anal

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) w

Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(0.10) per share which beat the anal

Abeona Therapeutics Inc. (NASDAQ:ABEO), a commercial-stage biopharmaceutical company developing cell

ABO-503 is composed of a functional human RS1 gene packaged in the novel AIM™ capsid AAV204. ABO-503

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) w

  On Wednesday, 807 companies reached new 52-week lows.

  On Friday, 1043 companies hit new 52-week lows.

  During Wednesday's trading, 435 companies set new 52-week lows.

Gainers

Gainers LMP Automotive Holdings, Inc. (NASDAQ: LMPX) shares surged 69.7% to close at $11.81 on Mo

Gainers Stein Mart, Inc. (NASDAQ: SMRT) shares climbed 87.4% to $0.2050 after dropping 11% on Fr

78 Biggest Movers From Yesterday

51 Stocks Moving In Wednesday's Mid-Day Session

80 Biggest Movers From Yesterday

58 Stocks Moving In Monday's Mid-Day Session

71 Biggest Movers From Yesterday

Stocks That Hit 52-Week Lows Of Monday

New 52-Week Lows For Monday Morning

New 52-Week Lows for Tuesday Morning

Stocks That Managed to Breach 52-Week Lows Friday

56 Biggest Movers From Yesterday